6-(3,4-dimethoxyphenyl)-2-methyl-4-(2,4,6-trimethylphenoxy)pyrimidine

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 英文名称: 6-(3,4-dimethoxyphenyl)-2-methyl-4-(2,4,6-trimethylphenoxy)pyrimidine
• 英文别名: 4-(3,4-dimethoxyphenyl)-2-methyl-6-(2,4,6-trimethylphenoxy)pyrimidine
• 化学式: C₂₂H₂₄N₂O₃
• 分子量: 364.444
• InChiKey: MQUGKDXHFCTRAR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.2
• 重原子数：
  27
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  53.5
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  4-chloro-6-(3,4-dimethoxyphenyl)-2-methylpyrimidine 、 2,4,6-三甲酚 以 N,N-二甲基甲酰胺 为溶剂， 生成 6-(3,4-dimethoxyphenyl)-2-methyl-4-(2,4,6-trimethylphenoxy)pyrimidine
  参考文献：
  名称：

  Pyrimidine compounds having activity as a cardiotonic anti-hypertensive

  摘要：

  该发明涉及具有以下结构式的嘧啶化合物：##STR1## 其中取代基R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5和R.sup.6如本文所定义，具有作为心力衰竭药、抗高血压药、脑血管扩张剂和抗血小板聚集剂的活性。

  公开号：

  US04725600A1

文献信息

• Pyrimidine derivatives, processes for preparation thereof and use thereof
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP0168262A2

  公开（公告）日：1986-01-15

  A pyrimidine derivative of the formula : wherein R' is hydrogen, aryl optionally having substituent(s) selected from lower alkoxy, lower alkyl, halogen and lower +alkylthio or , in which N D is a N-containing heterocyclic group; R2 is a) =N-R2 or in which R2 is aryl optionally substituted with lower alkyl, lower alkoxy, amino and/or acylamino and is hydrogen or lower alkyl, -N B is a N-containing heterocyclic group optionally substituted with acyl and/or ar(lower) alkyl; R3 is hydrogen or lower alkyl; R4 is a) imino optionally substituted with lower alkyl, aryl or ar(lower)alkyl, or b) lower alkyl, hydrogen, halogen, lower alkylthio, amino optionally substituted with lower alkyl, aryl, ar(lower)alkyl and/or acyl, or hydrazino optionally substituted with acyl, in which is a N-containing heterocyclic goup optionally substituted with acyl, and/or ar(lower)alkyl; R5 is hydrogen, lower alkyl, lower alkanoyl optionally substituted with lower alkylamino or no significance; or R3 and R4 or R4 and R5 are taken together with the adjacent nitrogen atom and carbon atom to form a N-containing heterocyclic ring; R6 is hydrogen, lower alkyl, halogen or aryl optionally having substituent(s) selected from lower alkoxy, lower alkyl, halogen and lower alkylthio substituents; the bond represents single bond or double bond; and the dotted line in the ring A represents one, two or three additional C-C and/or C-N bond(s) in the ring system, provided that R' and R6 are not both hydrogen; and pharmaceutically acceptable salt thereof. These compounds are useful in the treatment of heart disease, hypertension, cerebrovascular disease and thrombosis. Processes for the preparation of these compounds are also described, together with novel starting compounds for use in such processes and pharmaceutical compositions comprising pyrimidine derivatives of the above formula.

  式中的嘧啶衍生物 其中 R'是氢、可任选具有选自低级烷氧基、低级烷基、卤素和低级 +其中 N D 是含 N 的杂环基团； R2 是 a) =N-R2 或 其中 R2 是可选被低级烷基、低级烷氧基、氨基和/或酰氨基取代的芳基，并且是氢或低级烷基，-N B 是可选被酰基和/或芳基（低级）取代的含 N 杂环基团； R3 是氢或低级烷基； R4 是 a) 可选择被低级烷基、芳基或芳基取代的亚氨基，或 b) 低级烷基、氢、卤素、低级烷硫基、可选择被低级烷基、芳基、芳基和/或酰基取代的氨基、 或可选被酰基取代的肼，其中 是任选被酰基和/或芳基（低级）烷基取代的含 N 杂环基团； R5 是氢、低级烷基、任选被低级烷基氨基取代的低级烷酰基或无意义；或 R3 和 R4 或 R4 和 R5 与相邻的氮原子和碳原子一起形成含 N 的杂环； R6 是氢、低级烷基、卤素或芳基，可选择具有选自低级烷氧基、低级烷基、卤素和低级烷硫基的取代基； 键代表单键或双键；以及 环 A 中的虚线代表环系中一个、两个或三个额外的 C-C 和/或 C-N 键，条件是 R' 和 R6 不同时为氢；及其药学上可接受的盐。 这些化合物可用于治疗心脏病、高血压、脑血管疾病和血栓形成。 本文还描述了制备这些化合物的工艺，以及用于此类工艺的新型起始化合物和包含上式嘧啶衍生物的药物组合物。
• US4725600A
  申请人：——

  公开号：US4725600A

  公开（公告）日：1988-02-16
• Pyrimidine compounds having activity as a cardiotonic anti-hypertensive
  申请人：Fujisawa Pharmaceutical Co., Ltd.

  公开号：US04725600A1

  公开（公告）日：1988-02-16

  The invention relates to pyrimidine compounds of the formula: ##STR1## wherein the substituents R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as herein defined, having activity as a cardiotonic, anti-hypertensive, cerebrovascular vasodilator and anti-platelet aggregation agent.

  该发明涉及具有以下结构式的嘧啶化合物：##STR1## 其中取代基R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5和R.sup.6如本文所定义，具有作为心力衰竭药、抗高血压药、脑血管扩张剂和抗血小板聚集剂的活性。